Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: Clinical and neuropathological findings in 27 patients

Annals of Neurology

Volumn 19, Issue 3, 1986, Pages 224-238

  Navia, Bradford A ^a   Petito, Carol K ^a   Gold, Jonathan W M ^a   Cho, Eun‐Sook ^b   Jordan, Barry D ^a   Price, Richard W ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PYRIMETHAMINE; SULFANILAMIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; HUMAN; PRIORITY JOURNAL; THERAPY; TOXOPLASMOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; BIOPSY; BRAIN DISEASES; CENTRAL NERVOUS SYSTEM; CLINDAMYCIN; HUMANS; MALE; MIDDLE AGED; PYRIMETHAMINE; SEROLOGY; SULFONAMIDES; TOMOGRAPHY, X-RAY COMPUTED; TOXOPLASMOSIS;

EID: 0022569904     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410190303     Document Type: Article

References (57)

1. Cerebral toxoplasmosis in acquired immune deficiency syndrome
2. Central nervous system toxoplasmosis in homosexual men
3. Isolation of a Tlymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)
4. Neuropathological and computerized tomographic findings in experimental brain abscess
5. Neurological complications in acquired immunodeficiency syndrome (AIDS)
6. Toxoplasmosis—clinical experiences in a cancer hospital
7. Toxoplasma gondii infection of the central nervous system—use of the peroxidase‐antiperoxidase method to demonstrate toxoplasma in formalin fixed paraffin embedded tissue sections
8. Fatal CNS toxoplasmosis in a homosexual man
9. CT of central nervous system infections in immunocompromised patients
10. Experimental brain abscess evolution: computed tomographic and neuropathologic correlation
11. Cho E‐S, et al: HTLV‐III/LAV–like retrovirus particles in the brains of patients with AIDS encephalopathy
12. Immunologic abnormalities in the acquired immunodeficiency syndrome (AIDS)
13. Glucosteroid therapy: mechanisms of action and clinical considerations
14. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations
15. A micromodification of the
16. Immunosuppression and toxoplasmic encephalitis
17. Toxoplasmosis of the central nervous system in the adult
18. A morphologic study of opportunistic cerebral toxoplasmosis
19. Adult toxoplasmosis presenting as polymyositis and cerebellar ataxia
20. Toxoplasmosis—problems in diagnosis and treatment
21. Bacterial infections of the central nervous system
22. Central‐nervous‐system toxoplasmosis in homosexual and heterosexual adults
23. Central nervous system infection in the chronically immunosuppressed
24. CNS toxoplasmosis in acquired immunodeficiency syndrome
25. Use of avidin‐biotin‐peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures
26. Chronological development of cellular immunity in human toxoplasmosis
27. Neurological syndromes complicating AIDS
28. Computer‐assisted tomography in primary malignant lymphomas of the brain
29. Toxoplasmosis in the adult—an overview
30. Central nervous system mass lesions in the acquired immunodeficiency syndrome (AIDS)
31. Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome
32. Outbreak of central nervous system toxoplasmosis in Western Europe and North America
33. Effect of hydrocortisone on macrophage response to lymphokine
34. Toxoplasmosis presenting as brain abscesses—diagnosis by computerized tomography and cytology of aspirated purulent material
35. Influence of infection with Toxoplasma on macrophage function, and role of macrophages in resistance to Toxoplasma
36. Cerebral toxoplasmosis in the adult
37. Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome
38. Myelopathy pathologically resembling subacute combined degeneration in patients with acquired immunodeficiency syndrome (AIDS)
39. Opportunistic infections and Kaposi's sarcoma among Haitians: evidence of a new acquired immunodeficiency state
40. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV‐III) from patients with AIDS and pre‐AIDS
41. Toxoplasma encephalitis in Haitian adults with acquired immunodeficiency syndrome: a clinical‐pathologic‐CT correlation
42. Toxoplasmosis in the adult
43. IgM antibodies in acute toxoplasmosis: I. I. Prevalence and significance in acquired cases
44. Toxoplasmosis in the compromised host
45. Pneumocystis carinii, Toxoplasma gondii, cytomegalovirus and the compromised host
46. HTLV‐III infection in brains of children and adults with AIDS encephalopathy
47. Circulating immune complexes in toxoplasmosis: detection and clinical correlates
48. Brain stem toxoplasmosis complicating Hodgkin's disease
49. Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients
50. Demonstration of lesions of cerebral toxoplasmosis by computerized tomography
51. Acquired toxoplasmosis—a neglected cause of treatable nervous system disease
52. The parasitology of toxoplasmosis in the central nervous system
53. Toxoplasmosis complicating malignancy—experience at the National Cancer Institute
54. Kaposi's sarcoma and Toxoplasma gondii brain abscess in a Spanish homosexual
55. Cerebral blindness and oculomotor nerve palsies in toxoplasmosis
56. Central nervous system toxoplasmosis in homosexual men and parenteral drug abusers